pandemrix pandemrix pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. the vaccine was developed by glaxosmithkline (gsk) and patented in september 2006. pandemrixvaccine descriptiontargetpandemic h1n1/09 virusvaccine typeinactivatedclinical dataroutes ofadministrationintramuscular injectionatc codej07bb02 (who) legal statuslegal status uk: p (pharmacy medicines) eu: rx-only identifierscas number1385778-30-2chemspidernone ny (what is this?) (verify) influenza (flu) types avian a/h5n1 subtype canine equine swine a/h1n1 subtype vaccines 2009 pandemic pandemrix live attenuated seasonal flu vaccine brands treatment amantadine baloxavir marboxil laninamivir oseltamivir peramivir rimantadine umifenovir zanamivir pandemics 1889-1890 russian flu 1918 spanish flu 1957-1958 asian flu 1968 hong kong flu 1977 russian flu 2009 swine flu outbreaks 1976 swine flu 2006 h5n1 india 2007 australian equine 2007 bernard matthews h5n1 2008 west bengal 2015 united states h5n2 outbreak 2020–2022 h5n8 outbreak